FDA approves new combination vaccine that protects children against two bacterial diseases

The U.S. Food and Drug Administration today approved Menhibrix, a combination vaccine for infants and children ages 6 weeks through 18 months, for prevention of invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm308350.htm